Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Omobolanle A. Abidakun
Institution:
University at Buffalo, State University of New York
Observed institution:
University at Buffalo, State University of New York
ORCID:
0000-0002-2009-947X
Observed ORCID:
0000-0002-2009-947X
OpenAlex ID:
A5114971253
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent “Type V” Kinase Inhibitors
2024
·
Florian Wittlinger
, Surbhi P. Chitnis
, et al.
·
Journal of Medicinal Chemistry
·
16
PDF
Profiling and Optimizing Targeted Covalent Inhibitors through EGFR-Guided Studies
2025
·
Tahereh Damghani
, Surbhi P. Chitnis
, et al.
·
Journal of Medicinal Chemistry
·
14
Enhancing Selectivity and Potency of S N Ar Covalent Inhibitors of NADPH Oxidase Enzymes
2025
·
Blessing C. Ogboo
, Kishan B. Patel
, et al.
·
Journal of Medicinal Chemistry
·
8
Structural Insights into Brain-Penetrant EGFR Tyrosine Kinase Inhibitors with Enhanced Potency
2026
·
Abigail M. Lantry
, Tess M. Weber
, et al.
·
ACS Medicinal Chemistry Letters
·
2
PDF
Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors
2026
·
Kishan B. Patel
, Ishola A. Akinwumi
, et al.
·
Journal of Medicinal Chemistry
·
1
Show more works
View as search
Works count:
5
Citation count:
41
H-index:
3
I10-index:
2
Year
Topic
Type